Maxiocel
Management of chronic and acute wounds
CommercialActive
Key Facts
About Advamedica
Advamedica is a private, commercial-stage medical device company leveraging a proprietary biomaterials platform to develop and commercialize hemostatic and wound care products. Its flagship products, including Axiostat and Maxiocel, have gained regulatory clearances in the US and over 40 other countries, targeting the cardiovascular and trauma care markets. The company is backed by notable venture capital firms and maintains a strategic presence in key US innovation hubs like Cambridge, Massachusetts, and San Diego, California.
View full company profile